3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with cyclosporine in 3 studies
| Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 36 | 1 | 1 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burdick, JF; Klassen, DK; Weir, MR | 1 |
| Bennett, WM; Cannon, C; Hefty, DJ; Jasani, MK; Johnston, T; Kubacki, VB; Martin, LL; Rakhit, A; Schaffer, AV; Smith, SR | 1 |
| Grieve, EM; Hawksworth, GM; Simpson, JG; Whiting, PH | 1 |
3 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and cyclosporine
| Article | Year |
|---|---|
A pilot study to assess the ability of an orally available selective thromboxane synthase inhibitor to improve renal function in cyclosporine-treated renal transplant recipients.
Topics: Administration, Oral; Adult; Cyclosporine; Eicosanoids; Female; Hemodynamics; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Male; Pilot Projects; Pyridines; Thromboxane-A Synthase | 1992 |
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.
Topics: Adult; Cyclosporine; Glomerular Filtration Rate; Humans; Kidney; Kidney Transplantation; Middle Aged; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1993 |
The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
Topics: Animals; Body Weight; Cyclosporine; Enzyme Inhibitors; Kidney Diseases; Male; Prostaglandins; Pyridines; Rats; Rats, Sprague-Dawley; Thromboxane B2; Thromboxane-A Synthase | 1993 |